On February 18, 2025, GSK plc's Chief Scientific Officer, Tony Wood, received a cash payment of £247,942.28 from the vesting of 17,182.417 ordinary shares as part of the company's Deferred Investment Award Programme. This filing is a formal notification of his shareholding change.